FierceBiotech

Flexion Therapeutics Expands Supply Capacity for FX006 by Entering Into Agreement With Patheon

- Adding Patheon as a contract manufacturer, in addition to Evonik Corporation, bolsters manufacturing capacity for planned commercialization of company's lead program BURLINGTON, Mass. -- Flexion ...
FierceBiotech

Flexion Therapeutics Announces Pricing of Initial Public Offering

BURLINGTON, Mass. -- Flexion Therapeutics, Inc. FLXN 0.00%announced today the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $13.00 per share.
Business Insider

Flexion Reports Year-End 2016 Financial Results

BURLINGTON, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today reported financial results for the year-ended December 31, 2016 and provided an update on the ...
The Business Journals

Flexion reports positive data for osteoarthritis drug

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Flexion Therapeutics Inc. said Wednesday that its sustained ...